-+ 0.00%
-+ 0.00%
-+ 0.00%

On December 1, the clinical trial application for the new Chia Tai Tianqing Class 1 drug TQF3250 capsules was approved by the US Food and Drug Administration for weight loss indications.

Zhitongcaijing·12/04/2025 00:33:03
Listen to the news
On December 1, the clinical trial application for the new Chia Tai Tianqing Class 1 drug TQF3250 capsules was approved by the US Food and Drug Administration for weight loss indications.